Abogen
Abogen Biosciences (Suzhou Abogen Biosciences Co., Ltd. / 苏州艾博生物科技有限公司) is a clinical-stage biotechnology company founded in January 2019 and headquartered in Suzhou, China, dedicated to developing transformative medicines through messenger RNA (mRNA) innovation. The company has built full-scale in-house capabilities spanning the entire mRNA drug development cycle - protein engineering, mRNA sequence design and synthesis, proprietary lipid nanoparticle (LNP) delivery, formulation, and commercial-scale manufacturing. Its product pipeline covers infectious disease prevention and cancer immunotherapy, and it has advanced an EUA mRNA product along with additional clinical-stage candidates. Abogen is a portfolio company of the SoftBank Vision Fund. Abogen is a pharmaceutical / biotechnology company and does not currently publish a public developer platform, API, or SDK; this profile captures its corporate identity in the API Evangelist network.
Abogen is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Pharmaceuticals, and mRNA.
Abogen’s developer surface includes support and 2 more developer resources.
Kin Score
Resources
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API